Virtual Grand Rounds
Listen to important updates from Greenberg Bladder Cancer Institute leaders, hosted by Dr. David McConkey, GBCI Director. This virtual Zoom series focused on engaging the broader bladder cancer patient/family/advocacy community. Our program consists of a one-hour Zoom webinar (20-25 minutes with slides / 40-minute conversational Q&A). An opportunity to "chat" with experts. All sessions are free of charge. Click here for information about our upcoming Virtual Grand Rounds. To register for any of our five sessions, please complete the registration form.
Recordings of Past Virtual Grand Rounds
2024 Grand Rounds
A Multi-Disciplinary Care Model For Patients with Muscle Invasive Bladder Cancer
Improving the Health and Health Care of Older Adults with Multiple Conditions
Let's Hear it for the Lab!
On February 13th, Dr David McConkey, Director of the Johns Hopkins Greenberg Bladder Cancer Institute, provides a tour of the research into bladder cancer conducted at Johns Hopkins with GBCI Lab Team Members: Kai Aragaki, Chisom Okereke, MPH, Stephan Bronimann, and Stan Rapiey, Institute Co-Founder & Advocate Stephanie Cooper Greenberg will moderate the session
We Hear You: Questions Asked and Answered
On April 2nd, Dr Jean Hoffman-Censits, MD and Dr Nirmish Singla, MD, MSc answer questions for patients with Upper-Tract Urothelial Carcinoma
In English: A Review Of What Is Happening In Bladder Cancer Research What It Means And Why It Matter
On January 23rd, David McConkey, PhD, Professor of Urology and Oncology and Director of the Greenberg Bladder Cancer Institute, leads a Grand Rounds.
Spare Me
On September 10th, urologic surgeons and members of the Greenberg Bladder Cancer Institutre - Dr. Armine Smith and Dr. Max Kates for an informative session on new thinking about Bladder Cancer surgery with a specific emphasis on nerve and organ sparing techniques for bladder cancer patients.
2023 Grand Rounds
Bladder Cancer and the Microbiome: Understanding Complex Interactions
Cynthia Sears, MD, Bloomberg~Kimmel Professor of Cancer Immunotherapy and Professor of Medicine, leads a discussion about the relationship between bladder cancer and the microbiome moderated by Institute Co-Founder and Advocate Stephanie Cooper Greenberg. (Recorded 12/12/2023)
Kidney Health, UTUC, and Bladder Cancer: How They Are or Are Not Related
Dr. Nirmish Singla, Associate Professor of Urology, Dr. Jeannie Hoffman-Censits, Associate Professor of Oncology, and Dr. Derek Fine, Professor of Medicine, discuss the relationships between bladder cancer, upper tract urothelial cancer (UTUC), and kidney health. (Recorded 11/21/2023)
Clinical Trials: What It's Like to be Enrolled in a Clinical Trial
Noah Hahn, M.D., Deputy Director of the Johns Hopkins Greenberg Bladder Cancer Institute, discusses what patients can expect when they enroll in a bladder cancer clinical trial. (Recorded 10/10/2023)
Urinary Tract Infections and Basic Anatomy: UTI's Explained
Nirmish Singla, MD, MSc, Associate Professor of Urology, and Marisa Meyer Clifton, MD, Associate Professor of Urology, discuss urinary tract infections and their impact for bladder cancer patients in a discussion moderated by Institute Co-Founder and Advocate Stephanie Cooper Greenberg. (Recorded 9/19/2023)
Precision Medicine: Liquid Biopsies and Other Progress in Bladder Cancer Research
Johns Hopkins Greenberg Bladder Cancer Institute Director Dr. David McConkey presents and moderates a discussion about the exciting progress being made in bladder cancer research. (Recorded 5/2/2023)
Moving on After Treatments (for NMIBC & MIBC): Scans, Surveillance, and What to Expect When Treatments Stop
Urologist Dr. Max Kates, MD, Director of the Brady Urological Institute's Bladder Cancer Program, leads a conversation with a patient focused around what bladder cancer patients can expect after treatments stop, including scans and surveillance - how often and why. (Recorded 4/18/2023)
Chemobrain (Yes, It’s Real): Untangling Cognitive Dysfunction in Cancer Therapy
Dr. Tracy Vannorsdall, Associate Professor of Psychiatry and Behavioral Sciences, joins Johns Hopkins Greenberg Bladder Cancer Institute Director Dr. David McConkey to discuss the cognitive impacts of cancer therapy, informally known as "Chemobrain". (Recorded 3/28/2023)
New Tools in the Toolbox Explained: A Conversation About New Drugs & Therapies for Bladder Cancer
Dr. Jean Hoffman-Censits, Associate Professor of Oncology, joins Johns Hopkins Greenberg Bladder Cancer Institute Director Dr. David McConkey to discuss new advances in bladder cancer treatment. (Recorded 2/28/2023)
Is it OK to Get a 2nd Opinion and is it OK to Change My Care Team?
Dr. Nirmish Singla, Associate Professor of Urology, and UTUC Nurse Navigator Kristen Tyree discuss the ins and outs of second opinions and provide guidance for patients considering a new team of care providers. (Recorded 1/17/2023)
2022 Grand Rounds
Teamwork in Women's Bladder Cancer: The Advantage of the Multidisciplinary Approach
Drs. Armine Smith and Jean Hoffman-Censits, co-leaders of the Women's Bladder Cancer Program at the Johns Hopkins Greenberg Bladder Cancer Institute, discuss the benefits of multidisciplinary collaboration in the treatment of bladder cancer in women. (Recorded 12/13/2022)
Perspectives in Courage: A Patient & Urologist Conversation About Making Decisions on Procedures
Urologist Max Kates, MD, Director of the Brady Urological Institute's Bladder Cancer Program, speaks with a bladder cancer patient advocate about factors that influence treatment decisions. (Recorded 11/1/2022)
Turning Research into Results: Overview & Updates in Bladder Cancer Clinical Trials
Noah Hahn, M.D., Deputy Director of the Johns Hopkins Greenberg Bladder Cancer Institute, discusses exciting updates in bladder cancer clinical trials. (Recorded 10/11/2022)
When Cancer Spreads: an Introduction to Metastasis
Dr. Andrew Ewald, PhD, Director of the Department of Cell Biology, and Dr. David McConkey, PhD, Director of the Greenberg Bladder Cancer Institute, discuss the basics of cancer metastasis. (Recorded 9/20/2022)
Treating the Whole Patient: a Conversation on Clinical Care Collaboration in Bladder Cancer
Oncologist Noah Hahn, MD, Deputy Director of the Greenberg Bladder Cancer Institute, and urologist Max Kates, MD, Director of the Brady Urological Institute's Bladder Cancer Program, lead a conversation on clinical team collaboration and multi-disciplinary care in bladder cancer. (Recorded 5/9/2022)
It's All Around You: Potential Environmental Causes of Bladder Cancer
Sunil Patel, MD, MA, Instructor of Urology, leads a discussion about his research into potential environmental causes of bladder cancer, such as smoking and microplastics for the Greenberg Bladder Cancer Institute. (Recorded 4/19/2022)
Quality Cancer Care: A Conversation About the Facts You Need to Know
Internationally recognized medical oncologist, Otis Brawley, MD, Johns Hopkins Bloomberg Distinguished Professor and Associate Director of Community Outreach and Engagement at the Sidney Kimmel Comprehensive Cancer Center, leads a conversation with Institute Co-founder Stephanie Cooper Greenberg and Institute Director Dr. David McConkey about health disparities and important work underway to provide quality medical and cancer care at Johns Hopkins and across the country. (Recorded 3/8/2022)
It's All Related: Kidney Health for Bladder Cancer Patients
GBCI urologist Nirmish Singla, MD, MSc, discusses kidney health for bladder cancer patients, and how "It's All Related". (Recorded 2/22/2022)
Bladder Cancer 101: A Primer of Biology & Terminology
GBCI specialist Burles "Rusty" Johnson, MD, PhD, explains the basics of bladder cancer science, providing patients and caregivers with a primer of biology and medical terminology. (Recorded 1/25/2022)
2021 Grand Rounds
What is Bladder Cancer Tumor Sequencing and How Does it Work?
GBCI Director Dr. David McConkey and Co-Director Dr. Noah Hahn explain tumor sequencing and help patients attain a fuller understanding as its use as a valuable tool for bladder cancer care and research. (Recorded 12/7/2021)
The Unsung Heroes: Caring for the Caregiver
A lively conversation with renowned oncology nurse navigator Lillie Shockney in conversation about the invaluable, and indispensable, role of the caregiver for all cancer patients, especially bladder cancer, hosted by patient advocate Stephanie Cooper Greenberg. (Recorded 11/9/2021)
Upper Tract Urothelial Cancer: It's a Team Effort
A look into when doctors get together, go over cases and share their fields of expertise in bladder and upper tract cancers; a behind-the-scenes look at what takes place, who is present, and how care plans for patients are considered. Learn about the power of multidisciplinary care planning. (Recorded 10/12/2021)
Bladder Cancer Clinical Trials: What's it Like to be in a Clinical Trial
Featuring Bladder Cancer Survivor and Advocate Ken Brothers, author of ”Ken’s Cancer Blog” (http://kwbcancerblog.blogspot.com), in conversation with GBCI Co-Director, Dr. Noah Hahn, medical oncologist and clinical trial expert at Johns Hopkins Kimmel Cancer Center. (Recorded 9/27/2021)
Living With Bladder Cancer: Sexual Health
Amin S. Herati, M.D., Director of Male Infertility and Men's Health and Assistant Professor of Urology, Obstetrics & Gynecology at the Johns Hopkins University School of Medicine and partner of the Greenberg Bladder Cancer Institute, provides important information about the impacts of bladder cancer on sexual health. (Recorded 5/25/2021)
Depression and Bladder Cancer: It's Not Your Imagination
Glenn J. Treisman, M.D., Ph.D., Eugene Meyer III Professor of Psychiatry and Medicine at the Johns Hopkins University School of Medicine and partner with the Greenberg Bladder Cancer Institute, provides important information about depression in bladder cancer patients. (Recorded 4/6/2021)
Living with Bladder Cancer: When Bladder Removal is the Only Option
Max Kates, M.D., Assistant Professor of Urology & Oncology at the Johns Hopkins University School of Medicine and member of the Greenberg Bladder Cancer Institute, provides important information about living with bladder cancer in an open discussion with a patient. (Recorded 3/16/2021)
Decoding Bladder Cancer Pathology
Andres Matoso, M.D., Associate Professor of Pathology, Oncology & Urology and Director of Immunohistochemistry at the Johns Hopkins University School of Medicine and member of the Greenberg Bladder Cancer Institute, provides important information about bladder cancer pathology. (Recorded 2/16/2021)
Where Does Bladder Cancer Come From?
Elizabeth A. Platz, M.P.H., Sc.D., Deputy Chair of the Department of Epidemiology and Professor at the Johns Hopkins University Bloomberg School of Public Health, presents important information about the causes of bladder cancer. (Recorded 1/12/2021)
2020 Grand Rounds
Advances in Upper Tract Urothelial Cancer
Phillip M. Pierorazio, M.D., Associate Professor of Urology and Oncology at the Johns Hopkins University School of Medicine and member of the Greenberg Bladder Cancer Institute, presents important information about advances in upper tract urothelial cancer. (Recorded 12/15/2020)
Bladder Cancer Staging & Standards of Care
Trinity J. Bivalacqua, M.D., Ph.D., R. Christian B. Evensen Professor of Urology and Oncology and Director of Urologic Oncology at the Johns Hopkins University School of Medicine and member of the Greenberg Bladder Cancer Institute, presents important information about bladder cancer staging and standards of care. (Recorded 11/17/2020)
Clinical Trials and Immunotherapy
Jean Hoffman-Censits, M.D., Assistant Professor of Oncology and Urology at the Johns Hopkins University School of Medicine and member of the Greenberg Bladder Cancer Institute, provides an important update about clinical trials and immunotherapy for bladder cancer patients. (Recorded 10/13/2020)
BCG in Short Supply: New Alternatives and Options for Patients
Max Kates, M.D., Assistant Professor of Urology and Oncology at the Johns Hopkins University School of Medicine and member of the Greenberg Bladder Cancer Institute, provides an important update on the BCG shortage, providing alternatives and options for bladder cancer patients. (Recorded 9/15/2020)